
Orphan Drugs Global Market Report 2025
Description
Orphan Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on orphan drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for orphan drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The orphan drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Therapy Area: Oncology; Blood; Central Nervous System; Endocrine; Cardiovascular; Respiratory; Immunomodulatory
2) By Diseases Type: Oncology; Hematology; Neurology; Cardiovascular; Other Disease Types
3) By Drug Type: Biological; Non-Biological
4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Sales
Subsegments:
1) By Oncology: Targeted Therapies; Chemotherapy Agents; Immunotherapy Drugs; Hormonal Therapies
2) By Blood: Hematopoietic Growth Factors; Coagulation Factor Concentrates; Treatments for Rare Blood Disorders
3) By Central Nervous System: Medications for Rare Neurological Disorders; Antiepileptic Drugs for Rare Epilepsy Syndromes; Treatments for Rare Neurodegenerative Diseases
4) By Endocrine: Hormonal Replacement Therapies; Treatments for Rare Endocrine Disorders
5) By Cardiovascular: Medications for Rare Cardiovascular Conditions; Treatments for Rare Genetic Heart Disorders
6) By Respiratory: Therapies for Rare Respiratory Diseases; Medications for Rare Allergic Conditions
7) By Immunomodulatory: Treatments for Rare Autoimmune Disorders; Immunotherapies for Rare Inflammatory Conditions
Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; F Hoffmann-La Roche Ltd.; Farbenfabriken Bayer AG; Novartis AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
This report focuses on orphan drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for orphan drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The orphan drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Therapy Area: Oncology; Blood; Central Nervous System; Endocrine; Cardiovascular; Respiratory; Immunomodulatory
2) By Diseases Type: Oncology; Hematology; Neurology; Cardiovascular; Other Disease Types
3) By Drug Type: Biological; Non-Biological
4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Sales
Subsegments:
1) By Oncology: Targeted Therapies; Chemotherapy Agents; Immunotherapy Drugs; Hormonal Therapies
2) By Blood: Hematopoietic Growth Factors; Coagulation Factor Concentrates; Treatments for Rare Blood Disorders
3) By Central Nervous System: Medications for Rare Neurological Disorders; Antiepileptic Drugs for Rare Epilepsy Syndromes; Treatments for Rare Neurodegenerative Diseases
4) By Endocrine: Hormonal Replacement Therapies; Treatments for Rare Endocrine Disorders
5) By Cardiovascular: Medications for Rare Cardiovascular Conditions; Treatments for Rare Genetic Heart Disorders
6) By Respiratory: Therapies for Rare Respiratory Diseases; Medications for Rare Allergic Conditions
7) By Immunomodulatory: Treatments for Rare Autoimmune Disorders; Immunotherapies for Rare Inflammatory Conditions
Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; F Hoffmann-La Roche Ltd.; Farbenfabriken Bayer AG; Novartis AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
175 Pages
- 1. Executive Summary
- 2. Orphan Drugs Market Characteristics
- 3. Orphan Drugs Market Trends And Strategies
- 4. Orphan Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
- 5. Global Orphan Drugs Growth Analysis And Strategic Analysis Framework
- 5.1. Global Orphan Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Orphan Drugs Market Growth Rate Analysis
- 5.4. Global Orphan Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Orphan Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Orphan Drugs Total Addressable Market (TAM)
- 6. Orphan Drugs Market Segmentation
- 6.1. Global Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oncology
- Blood
- Central Nervous System
- Endocrine
- Cardiovascular
- Respiratory
- Immunomodulatory
- 6.2. Global Orphan Drugs Market, Segmentation By Diseases Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oncology
- Hematology
- Neurology
- Cardiovascular
- Other Diesease Types
- 6.3. Global Orphan Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Biological
- Non-Biological
- 6.4. Global Orphan Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacy
- Retail Pharmacy
- Online Sales
- 6.5. Global Orphan Drugs Market, Sub-Segmentation Of Oncology, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Targeted Therapies
- Chemotherapy Agents
- Immunotherapy Drugs
- Hormonal Therapies
- 6.6. Global Orphan Drugs Market, Sub-Segmentation Of Blood, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hematopoietic Growth Factors
- Coagulation Factor Concentrates
- Treatments for Rare Blood Disorders
- 6.7. Global Orphan Drugs Market, Sub-Segmentation Of Central Nervous System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Medications for Rare Neurological Disorders
- Antiepileptic Drugs for Rare Epilepsy Syndromes
- Treatments for Rare Neurodegenerative Diseases
- 6.8. Global Orphan Drugs Market, Sub-Segmentation Of Endocrine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hormonal Replacement Therapies
- Treatments for Rare Endocrine Disorders
- 6.9. Global Orphan Drugs Market, Sub-Segmentation Of Cardiovascular, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Medications for Rare Cardiovascular Conditions
- Treatments for Rare Genetic Heart Disorders
- 6.10. Global Orphan Drugs Market, Sub-Segmentation Of Respiratory, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Therapies for Rare Respiratory Diseases
- Medications for Rare Allergic Conditions
- 6.11. Global Orphan Drugs Market, Sub-Segmentation Of Immunomodulatory, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Treatments for Rare Autoimmune Disorders
- Immunotherapies for Rare Inflammatory Conditions
- 7. Orphan Drugs Market Regional And Country Analysis
- 7.1. Global Orphan Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Orphan Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific Orphan Drugs Market
- 8.1. Asia-Pacific Orphan Drugs Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Orphan Drugs Market, Segmentation By Diseases Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Orphan Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China Orphan Drugs Market
- 9.1. China Orphan Drugs Market Overview
- 9.2. China Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Orphan Drugs Market, Segmentation By Diseases Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Orphan Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India Orphan Drugs Market
- 10.1. India Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Orphan Drugs Market, Segmentation By Diseases Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Orphan Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan Orphan Drugs Market
- 11.1. Japan Orphan Drugs Market Overview
- 11.2. Japan Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Orphan Drugs Market, Segmentation By Diseases Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Orphan Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia Orphan Drugs Market
- 12.1. Australia Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Orphan Drugs Market, Segmentation By Diseases Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Orphan Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia Orphan Drugs Market
- 13.1. Indonesia Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Orphan Drugs Market, Segmentation By Diseases Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Orphan Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea Orphan Drugs Market
- 14.1. South Korea Orphan Drugs Market Overview
- 14.2. South Korea Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Orphan Drugs Market, Segmentation By Diseases Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Orphan Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe Orphan Drugs Market
- 15.1. Western Europe Orphan Drugs Market Overview
- 15.2. Western Europe Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Orphan Drugs Market, Segmentation By Diseases Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Orphan Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK Orphan Drugs Market
- 16.1. UK Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Orphan Drugs Market, Segmentation By Diseases Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Orphan Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany Orphan Drugs Market
- 17.1. Germany Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Orphan Drugs Market, Segmentation By Diseases Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Orphan Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France Orphan Drugs Market
- 18.1. France Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Orphan Drugs Market, Segmentation By Diseases Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Orphan Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy Orphan Drugs Market
- 19.1. Italy Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Orphan Drugs Market, Segmentation By Diseases Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Orphan Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain Orphan Drugs Market
- 20.1. Spain Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Orphan Drugs Market, Segmentation By Diseases Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Orphan Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Orphan Drugs Market
- 21.1. Eastern Europe Orphan Drugs Market Overview
- 21.2. Eastern Europe Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Orphan Drugs Market, Segmentation By Diseases Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Orphan Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia Orphan Drugs Market
- 22.1. Russia Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Orphan Drugs Market, Segmentation By Diseases Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Orphan Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America Orphan Drugs Market
- 23.1. North America Orphan Drugs Market Overview
- 23.2. North America Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Orphan Drugs Market, Segmentation By Diseases Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Orphan Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA Orphan Drugs Market
- 24.1. USA Orphan Drugs Market Overview
- 24.2. USA Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Orphan Drugs Market, Segmentation By Diseases Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Orphan Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada Orphan Drugs Market
- 25.1. Canada Orphan Drugs Market Overview
- 25.2. Canada Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Orphan Drugs Market, Segmentation By Diseases Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Orphan Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America Orphan Drugs Market
- 26.1. South America Orphan Drugs Market Overview
- 26.2. South America Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Orphan Drugs Market, Segmentation By Diseases Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Orphan Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil Orphan Drugs Market
- 27.1. Brazil Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Orphan Drugs Market, Segmentation By Diseases Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Orphan Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East Orphan Drugs Market
- 28.1. Middle East Orphan Drugs Market Overview
- 28.2. Middle East Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Orphan Drugs Market, Segmentation By Diseases Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Orphan Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa Orphan Drugs Market
- 29.1. Africa Orphan Drugs Market Overview
- 29.2. Africa Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Orphan Drugs Market, Segmentation By Diseases Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Orphan Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. Orphan Drugs Market Competitive Landscape And Company Profiles
- 30.1. Orphan Drugs Market Competitive Landscape
- 30.2. Orphan Drugs Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. F Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Farbenfabriken Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 31. Orphan Drugs Market Other Major And Innovative Companies
- 31.1. Sanofi SA
- 31.2. Bristol-Myers Squibb Co.
- 31.3. AstraZeneca plc
- 31.4. GlaxoSmithKline plc
- 31.5. Takeda Pharmaceutical Company Limited
- 31.6. Eli Lilly and Company
- 31.7. Gilead Sciences Inc.
- 31.8. Applied Molecular Genetics Inc.
- 31.9. Novo Nordisk A/S
- 31.10. Merck & Co. KG
- 31.11. AbbVie Inc.
- 31.12. Teva Pharmaceutical Industries Ltd.
- 31.13. Regeneron Pharmaceuticals Inc.
- 31.14. CSL Limited
- 31.15. Biogen Inc.
- 32. Global Orphan Drugs Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The Orphan Drugs Market
- 34. Recent Developments In The Orphan Drugs Market
- 35. Orphan Drugs Market High Potential Countries, Segments and Strategies
- 35.1 Orphan Drugs Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Orphan Drugs Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Orphan Drugs Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.